Sacituzumab tirumotecan (SKB264)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sacituzumab tirumotecan (SKB264), covering 2026-04-03 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Sacituzumab Tirumotecan (SKB264) in Combination With Toripalimab in Patients With Initially Unresectable Stage III NSCLC [Phase 2]